ZIP1<sup>+</sup> fibroblasts protect lung cancer against chemotherapy via connexin-43 mediated intercellular Zn<sup>2+</sup> transfer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36207295.
- Also identified by DOI 10.1038/s41467-022-33521-4 and PMC identifier 9547061.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Tumour-stroma cell interactions impact cancer progression and therapy responses. Intercellular communication between fibroblasts and cancer cells using various soluble mediators has often been reported. In this study, we find that a zinc-transporter (ZIP1) positive tumour-associated fibroblast subset is enriched after chemotherapy and directly interconnects lung cancer cells with gap junctions. Using single-cell RNA sequencing, we identify several fibroblast subpopulations, among which Zip1<sup>+</sup> fibroblasts are highly enriched in mouse lung tumours after doxorubicin treatment. ZIP1 expression on fibroblasts enhances gap junction formation in cancer cells by upregulating connexin-43. Acting as a Zn<sup>2+</sup> reservoir, ZIP1<sup>+</sup> fibroblasts absorb and transfer Zn<sup>2+</sup> to cancer cells, leading to ABCB1-mediated chemoresistance. Clinically, ZIP1<sup>high</sup> stromal fibroblasts are also associated with chemoresistance in human lung cancers. Taken together, our results reveal a mechanism by which fibroblasts interact directly with tumour cells via gap junctions and contribute to chemoresistance in lung cancer.
Medical subject headings
- Gap Junctions
- Lung Neoplasms